Showing results 1 to 22 of 22
Issue Date | Title | Author(s) |
---|---|---|
2024-04 | Accurately Controlled Tumor Temperature with Silica-Coated Gold Nanorods for Optimal Immune Checkpoint Blockade Therapy | Yun, Wan Su; Yang, Wonseok; Shim, Man Kyu; Song, Sukyung; Choi, Jiwoong; Kim, Jeongrae; Kim, Jinseong; Moon, Yujeong; SeongHoon, Jo; Lim, Dong-Kwon; Kim, Kwangmeyung |
2022-05 | Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death | Moon, Yujeong; Shim, Man Kyu; Choi, Jiwoong; Yang, Suah; Kim, Jinseong; Yun, Wan Su; Cho, Hanhee; Park, Jung Yeon; Kim, Yongju; Seong, Joon-Kyung; Kim, Kwangmeyung |
2021-05 | Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity | Yang, Suah; Shim, Man Kyu; Kim, Woo Jun; Choi, Jiwoong; Nam, Gi-Hoon; Kim, Jeongrae; Kim, Jinseong; Moon, Yujeong; Kim, Han Young; Park, Jooho; Park, Yoon; Kim, In-San; Ryu, Ju Hee; Kim, Kwangmeyung |
2021-02-10 | Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance | Kim, Jinseong; Shim, Man Kyu; Yang, Suah; Moon, Yujeong; Song, Sukyung; Choi, Jiwoong; Kim, Jeongrae; Kim, Kwangmeyung |
2022-10 | Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy | Shim, Nayeon; Jeon, Seong Ik; Yang, Suah; Park, Jung Yeon; Jo, Mihee; Kim, Jinseong; Choi, Jiwoong; Yun, Wan Su; Kim, Jeongrae; Lee, Youngjoo; Shim, Man Kyu; Kim, Yongju; Kim, Kwangmeyung |
2024-06 | Design of PD-L1-Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy | Kim, Yelee; Choi, Jiwoong; Kim, Eun Hye; Park, Wonbeom; Jang, Hochung; Jang, Yeongji; Chi, Sung-Gil; Kweon, Dae-Hyuk; Lee, Kyuri; Kim, Sun Hwa; Yang, Yoosoo |
2023-10 | Design of siRNA Bioconjugates for Efficient Control of Cancer-Associated Membrane Receptors | Lee, Jong Won; Choi, Jiwoong; Kim, Eun Hye; Choi, Jiwon; Kim, Sun Hwa; Yang, Yoosoo |
2025-01 | Drug repositioning of mesalamine via supramolecular nanoassembly for the treatment of drug-induced acute liver failure | Park, Byeongmin; Kim, Eun Hye; Jang, Hochung; Kim, Yelee; Ryu, Youngri; Choi, Jiwoong; Shin, Dongwon; LEE, MYUNG CHUL; Yang, Yoosoo; Kim, Kwangmeyung; Lee, Sangmin; Kim, Sun Hwa; Shim, Man Kyu |
2023-07 | Immune checkpoint-targeted drug conjugates: A promising tool for remodeling tumor immune microenvironment | Choi, Jiwoong; Jang, Hochung; Choi, Jiwon; Choi, Yeonho; Yang, Yoosoo; Shim, Man Kyu; Kim, Sun Hwa |
2022-10 | Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light | Choi, Jiwoong; Lee, Il Seong; Lee, Ju Seung; Jeon, Sangmin; Yun, Wan Su; Yang, Suah; Moon, Yujeong; Kim, Jinseong; Kim, Jeongrae; Choy, Seunghwan; Jeong, Chanho; Shim, Man Kyu; Kim, Tae-Il; 김광명 |
2024-07 | Implantable MicroLED-Mediated Chemo-Photodynamic Combination Therapy for Glioma Treatment | Kim, Jeongrae; Lee, Hin Kiu; Park, Junwon; Jeon, Seong Ik; Lee, Il Seong; Yun, Wan Su; MOON, YU JEONG; Choi, Jiwoong; Shim, Man Kyu; Kim, Jinseong; Cho, Hanhee; Shim, Nayeon; Hwang, Namcheol; Koirala, Gyan Raj; Gwak, Minjun; Han, Sangheon; Kim, DongHwee; Chang, Won Seok; Kim, Taeil; Kim, Kwangmeyung |
2024-09 | Light-Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy | Choi, Jiwoong; Park, Byeongmin; Park, Jung Yeon; Shin, Dongwon; Lee, Sangmin; Yoon, Hong Yeol; Kim, Kwangmeyung; Kim, Sun Hwa; Kim, Yongju; Yang, Yoosoo; Shim, Man Kyu |
2024-08 | Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs | Jang, Hochung; Choi, Jiwoong; Park, Daeho; Han, Geonhee; Kim, Eun Hye; Kim, Kwangmeyung; Kim, Sun Hwa; Shim, Man Kyu; Yang, Yoosoo |
2024-09 | Oral Delivery of Photoresponsive Milk-Derived Exosomes for the Local Therapy of Glioblastoma | Choi, Jiwoong; Jang, Hochung; Park, Daeho; Park, Byeongmin; Jang, Yeongji; Lee, Sangmin; Kim, Sun Hwa; Shim, Man Kyu; Yang, Yoosoo |
2022-05 | PDL1-binding peptide/anti-miRNA21 conjugate as a therapeutic modality for PD-L1high tumors and TAMs | Kim, Eun Hye; Lee, Jongwon; Kwak, Gijung; Jang, Hochung; Kim, Hyosuk; Cho, Haeun; Jang, Yeongji; Choi, Jiwoong; Chi, Sung Gil; Kim, Kwangmeyung; Kwon, Ick Chan; Yang, Yoosoo; Kim, Sun Hwa |
2024-11 | Stiffness-tunable velvet worm-inspired soft adhesive robot | Min, Hyeongho; Bae, Daebeom; Jang, Siyeon; Lee, Sangmin; Park, Myungjin; Dayan, Cem Balda; Choi, Jiwoong; Bak, Keungyonh; Yang, Yoosoo; Chun, Sungwoo; Sitti, Metin |
2022-03 | Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses | Kim, Jeongrae; Choi, Yongwhan; Yang, Suah; Lee, Jaewan; Choi, Jiwoong; Moon, Yujeong; Kim, Jinseong; Shim, Nayeon; Cho, Hanhee; Shim, Man Kyu; Jeon, Sangmin; Lim, Dong-Kwon; Yoon, Hong Yeol; Kim, Kwangmeyung |
2024-06 | Targeted delivery of anti-miRNA21 sensitizes PD-L1high tumor to immunotherapy by promoting immunogenic cell death | Kim, Eun Hye; Choi, Jiwoong; Jang, Hochung; Kim, Yelee; Lee, Jong Won; Ryu, Youngri; Choi, Jiwon; Choi, Yeonho; Chi, Sung-Gil; Kwon, Ick Chan; Yang, Yoosoo; Kim, Sun Hwa |
2024-10 | Targeting miR-21 to Overcome P-glycoprotein Drug Efflux in Doxorubicin-Resistant 4T1 Breast Cancer | Kim, Eun Hye; Ryu, Youngri; Choi, Jiwoong; Park, Daeho; Lee, Jong Won; Chi, Sung-Gil; Kim, Sun Hwa; Yang, Yoosoo |
2021-12 | The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis | Kim, Jinseong; Shim, Man Kyu; Cho, Young-Jae; Jeon, Sangmin; Moon, Yujeong; Choi, Jiwoong; Kim, Jeongrae; Lee, Jaewan; Lee, Jeong-Won; Kim, Kwangmeyung |
2023-08 | Thermally Managed, Injectable Optoelectronic Probe with Heat Dissipation Guide for Photodynamic Therapy | Lee, Ju Seung; Choi, Jiwoong; Park, Gha Yeon; Kang, Seung Ji; Yang, Jae-hun; Lee, Youngkyu; Choi, Myunghwan; Kim, Kwangmeyung; Kim, Tae-il |
2021-07-27 | Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy | Choi, Jiwoong; Shim, Man Kyu; Yang, Suah; Hwang, Hee Sook; Cho, Hanhee; Kim, Jeongrae; Yun, Wan Su; Moon, Yujeong; Kim, Jinseong; Yoon, Hong Yeol; Kim, Kwangmeyung |